Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Sunitinib in Advanced Renal Cell Carcinoma
NCT00975806Phase 2Terminated
- Sponsor
- Celgene Corporation
- Start
- Sep 2009
- Primary completion
- Oct 2011
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in renal cell carcinoma (RCC), sponsored by Celgene Corporation. Started Sep 2009; status: terminated.
02
Drugs
lenalidomide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00975806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975806.